{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T19:55:09Z","timestamp":1789415709129,"version":"build-2803163510"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,5]]},"abstract":"Summary<\/jats:title>\n \n Background and objectives<\/jats:title>\n \n Although percutaneous liver biopsy (PLB) is the gold standard for staging hepatic fibrosis in hemodialysis patients with chronic hepatitis C (CHC) before renal transplantation or antiviral therapy, concerns exist about serious postbiopsy complications. Using transient elastography (TE, Fibroscan\n \u00ae<\/jats:sup>\n ) to predict the severity of hepatic fibrosis has not been prospectively evaluated in these patients.\n <\/jats:p>\n <\/jats:sec>\n \n Design, setting, participants, & measurements<\/jats:title>\n A total of 284 hemodialysis patients with CHC were enrolled. TE and aspartate aminotransferase-to-platelet ratio index (APRI) were performed before PLB. The severity of hepatic fibrosis was staged by METAVIR scores ranging from F0 to F4. Receiver operating characteristic curves were used to assess the diagnostic accuracy of TE and APRI, taking PLB as the reference standard.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n The areas under curves of TE were higher than those of APRI in predicting patients with significant hepatic fibrosis (\u2265F2) (0.96\n versus<\/jats:italic>\n 0.84,\n P<\/jats:italic>\n < 0.001), those with advanced hepatic fibrosis (\u2265F3) (0.98\n versus<\/jats:italic>\n 0.93,\n P<\/jats:italic>\n = 0.04), and those with cirrhosis (F4) (0.99\n versus<\/jats:italic>\n 0.92,\n P<\/jats:italic>\n = 0.13). Choosing optimized liver stiffness measurements of 5.3, 8.3, and 9.2 kPa had high sensitivity (93\u2013100%) and specificity (88\u201399%), and 87, 97, and 93% of the patients with a fibrosis stage of \u2265F2, \u2265F3, and F4 were correctly diagnosed without PLB, respectively.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n TE is superior to APRI in assessing the severity of hepatic fibrosis and can substantially decrease the need of staging PLB in hemodialysis patients with CHC.<\/jats:p>\n <\/jats:sec>","DOI":"10.2215\/cjn.04320510","type":"journal-article","created":{"date-parts":[[2011,3,10]],"date-time":"2011-03-10T22:45:41Z","timestamp":1299797141000},"page":"1057-1065","source":"Crossref","is-referenced-by-count":69,"title":["Transient Elastography to Assess Hepatic Fibrosis in Hemodialysis Chronic Hepatitis C Patients"],"prefix":"10.2215","volume":"6","author":[{"given":"Chen-Hua","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Chao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Wen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Jen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-I","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jou-Wei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peir-Haur","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Bin","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Yang","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Jer","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Herng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ding-Shinn","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Horng","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-16-20230811","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/jhep.2002.34613","article-title":"Hepatitis C infection and the patient with end-stage renal disease","volume":"36","author":"Fabrizi","year":"2002","journal-title":"Hepatology"},{"key":"R2-16-20230811","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/hep.22545","article-title":"Treatment of chronic hepatitis C in hemodialysis patients","volume":"48","author":"Berenguer","year":"2008","journal-title":"Hepatology"},{"key":"R3-16-20230811","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.jhep.2008.06.003","article-title":"Hepatitis C virus and kidney disease","volume":"49","author":"Martin","year":"2008","journal-title":"J Hepatol"},{"key":"R4-16-20230811","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1440-1746.2010.06488.x","article-title":"Treatment of hepatitis C virus infection in patients with end-stage renal disease","volume":"26","author":"Liu","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"key":"R5-16-20230811","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1086\/655682","article-title":"Pegylated interferon alpha-2a monotherapy for hemodialysis patients with acute hepatitis C","volume":"51","author":"Liu","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R6-16-20230811","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1681\/ASN.V11101896","article-title":"Prognosis of anti-hepatitis C virus antibody-positive patients on regular hemodialysis therapy","volume":"11","author":"Nakayama","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"R7-16-20230811","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1111\/j.1365-2036.2004.02290.x","article-title":"Meta-analysis: Effect of hepatitis C virus infection on mortality in dialysis","volume":"20","author":"Fabrizi","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"R8-16-20230811","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/hep.510290123","article-title":"Impact of hepatitis B and C virus on kidney transplantation outcome","volume":"29","author":"Mathurin","year":"1999","journal-title":"Hepatology"},{"key":"R9-16-20230811","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2893.2008.00990.x","article-title":"Interferon monotherapy of chronic hepatitis C in dialysis patients: Meta-analysis of clinical trials","volume":"15","author":"Fabrizi","year":"2008","journal-title":"J Viral Hepat"},{"key":"R10-16-20230811","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1053\/j.ajkd.2007.11.003","article-title":"Interferon treatment in hemodialysis patients with chronic hepatitis C virus infection: A systematic review of the literature and meta-analysis of treatment efficacy and harms","volume":"51","author":"Gordon","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"R11-16-20230811","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1136\/gut.2007.133884","article-title":"Pegylated interferon alpha-2a versus standard interferon alpha-2a for treatment-naive dialysis patients with chronic hepatitis C: A randomised study","volume":"57","author":"Liu","year":"2008","journal-title":"Gut"},{"key":"R12-16-20230811","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1136\/gut.2008.165076","article-title":"Pegylated interferon alpha-2a plus low-dose ribavirin for the retreatment of dialysis chronic hepatitis C patients who relapsed from prior interferon monotherapy","volume":"58","author":"Liu","year":"2009","journal-title":"Gut"},{"key":"R13-16-20230811","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/S0140-6736(09)62195-4","article-title":"Non-invasive assessment of liver fibrosis: Are we ready?","volume":"375","author":"Cast\u00e9ra","year":"2010","journal-title":"Lancet"},{"key":"R14-16-20230811","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1056\/NEJM200102153440706","article-title":"Liver biopsy","volume":"344","author":"Bravo","year":"2001","journal-title":"N Engl J Med"},{"key":"R15-16-20230811","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.22742","article-title":"Liver biopsy","volume":"49","author":"Rockey","year":"2009","journal-title":"Hepatology"},{"key":"R16-16-20230811","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1159\/000189358","article-title":"Percutaneous liver biopsy complications in patients with chronic renal failure","volume":"74","author":"Ozdo\u011fan","year":"1996","journal-title":"Nephron"},{"key":"R17-16-20230811","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/00004836-200208000-00013","article-title":"Characteristics of hepatitis C in renal transplant candidates","volume":"35","author":"Cotler","year":"2002","journal-title":"J Clin Gastroenterol"},{"key":"R18-16-20230811","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.cgh.2007.07.010","article-title":"Percutaneous liver biopsy is safe in chronic hepatitis C patients with end-stage renal disease","volume":"5","author":"Pawa","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R19-16-20230811","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.thromres.2005.03.029","article-title":"Bleeding in patients with renal insufficiency: A practical guide to clinical management","volume":"118","author":"Gangji","year":"2006","journal-title":"Thromb Res"},{"key":"R20-16-20230811","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1525-139X.2006.00179.x","article-title":"Platelet dysfunction and end-stage renal disease","volume":"19","author":"Kaw","year":"2006","journal-title":"Semin Dial"},{"key":"R21-16-20230811","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0140-6736(86)90883-4","article-title":"Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver","volume":"1","author":"Maharaj","year":"1986","journal-title":"Lancet"},{"key":"R22-16-20230811","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.hep.2003.09.022","article-title":"Sampling variability of liver fibrosis in chronic hepatitis C","volume":"38","author":"Bedossa","year":"2003","journal-title":"Hepatology"},{"key":"R23-16-20230811","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"},{"key":"R24-16-20230811","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1111\/j.1478-3231.2006.01355.x","article-title":"Noninvasive tests for the prediction of significant hepatic fibrosis in hepatitis C virus carriers with persistently normal alanine aminotransferases","volume":"26","author":"Liu","year":"2006","journal-title":"Liver Int"},{"key":"R25-16-20230811","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/hep.21835","article-title":"Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C-related fibrosis: A systematic review","volume":"46","author":"Shaheen","year":"2007","journal-title":"Hepatology"},{"key":"R26-16-20230811","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.transproceed.2003.11.066","article-title":"Investigation of possible clinical and laboratory predictors of liver fibrosis in hemodialysis patients infected with hepatitis C virus","volume":"36","author":"Boyacio\u011flu","year":"2004","journal-title":"Transplant Proc"},{"key":"R27-16-20230811","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/hep.21681","article-title":"Simple blood tests as noninvasive markers of liver fibrosis in hemodialysis patients with chronic hepatitis C virus infection","volume":"46","author":"Schiavon","year":"2007","journal-title":"Hepatology"},{"key":"R28-16-20230811","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/ki.2010.74","article-title":"The ratio of aminotransferase to platelets is a useful index for predicting hepatic fibrosis in hemodialysis patients with chronic hepatitis C","volume":"78","author":"Liu","year":"2010","journal-title":"Kidney Int"},{"key":"R29-16-20230811","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.cgh.2007.07.020","article-title":"Ultrasound-based transient elastography for the detection of hepatic fibrosis: Systematic review and meta-analysis","volume":"5","author":"Talwalkar","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R30-16-20230811","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1053\/j.gastro.2008.01.034","article-title":"Performance of transient elastography for the staging of liver fibrosis: A meta-analysis","volume":"134","author":"Friedrich-Rust","year":"2008","journal-title":"Gastroenterology"},{"key":"R31-16-20230811","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.jhep.2008.02.008","article-title":"Non-invasive evaluation of liver fibrosis using transient elastography","volume":"48","author":"Cast\u00e9ra","year":"2008","journal-title":"J Hepatol"},{"key":"R32-16-20230811","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1053\/j.gastro.2004.11.018","article-title":"Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C","volume":"128","author":"Cast\u00e9ra","year":"2005","journal-title":"Gastroenterology"},{"key":"R33-16-20230811","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/hep.20506","article-title":"Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C","volume":"41","author":"Ziol","year":"2005","journal-title":"Hepatology"},{"key":"R34-16-20230811","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/hep.23425","article-title":"Pitfalls of liver stiffness measurement: A 5-year prospective study of 13,369 examinations","volume":"51","author":"Cast\u00e9ra","year":"2010","journal-title":"Hepatology"},{"key":"R35-16-20230811","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.510240201","article-title":"An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group","volume":"24","author":"Bedossa","year":"1996","journal-title":"Hepatology"},{"key":"R36-16-20230811","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1148\/radiology.148.3.6878708","article-title":"A method of comparing the areas under receiver operating characteristic curves derived from the same cases","volume":"148","author":"Hanley","year":"1983","journal-title":"Radiology"},{"key":"R37-16-20230811","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1053\/gast.2002.36572","article-title":"AGA technical review on nonalcoholic fatty liver disease","volume":"123","author":"Sanyal","year":"2002","journal-title":"Gastroenterology"},{"key":"R38-16-20230811","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1373\/clinchem.2007.085795","article-title":"Standardization of ROC curve areas for diagnostic evaluation of liver fibrosis markers based on prevalences of fibrosis stages","volume":"53","author":"Poynard","year":"2007","journal-title":"Clin Chem"},{"key":"R39-16-20230811","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1136\/gut.2006.111302","article-title":"Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease","volume":"56","author":"Fraquelli","year":"2007","journal-title":"Gut"},{"key":"R40-16-20230811","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jhep.2009.11.018","article-title":"Liver stiffness is directly influenced by central venous pressure","volume":"52","author":"Millonig","year":"2010","journal-title":"J Hepatol"},{"key":"R41-16-20230811","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1525-1594.2009.00925.x","article-title":"Dialysis reduces portal pressure in patients with chronic hepatitis C","volume":"34","author":"Khurana","year":"2010","journal-title":"Artif Organs"},{"key":"R42-16-20230811","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1111\/j.1478-3231.2009.02100.x","article-title":"Food intake increases liver stiffness in patients with chronic or resolved hepatitis C virus infection","volume":"29","author":"Mederacke","year":"2009","journal-title":"Liver Int"},{"key":"R43-16-20230811","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1365-2893.2006.00811.x","article-title":"Transient elastography: A new surrogate marker of liver fibrosis influenced by major changes of transaminases","volume":"14","author":"Coco","year":"2007","journal-title":"J Viral Hepat"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201105000-00016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:41:02Z","timestamp":1786369262000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201105000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.04320510","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}